DECODE – Talk Bio

Actionable Insights Powered by AI

Lilly Invests $85M Upfront in Repertoire Immune Medicines for Autoimmune Therapies Partnership

20 hours ago talkbio0Tagged Autoimmune Diseases, DECODE, eli lilly, Immune Medicines, milestones, Platform, Repertoire

Eli Lilly; Repertoire Immune Medicines; autoimmune diseases; DECODE platform; tolerizing therapies; $85M upfront; $1.84B milestones; Flagship Pioneering